Fructose-1,6-bisphosphatase (FBP) deficiency is a rare hereditary disorder that belongs to a group of metabolic disorders caused by a deficiency of an enzyme that plays a key role in glycolysis and gluconeogenesis. Deficiency of this enzyme leads to a disruption of carbohydrate metabolism, which in turn causes an accumulation of intermediate metabolites and impairs the energy supply of cells. The main manifestations of the disease are hypoglycemia, lactatosis, and an increase in the level of fats in the liver and kidneys. This condition usually manifests itself in childhood, but sometimes it can remain unnoticed until later.
History of the disease and interesting historical facts
The history of fructose-1,6-bisphosphatase deficiency research dates back to the first half of the 20th century, when scientists began to recognize the existence of metabolic disorders associated with specific enzyme deficiencies. The first descriptions of the disease appeared in the 1950s, when clinical manifestations were noted in children who suffered from severe metabolic disturbances. In the 1960s, significant breakthroughs in biochemistry occurred, which allowed the structure and function of FBP to be detailed. At this time, scientists also began to identify hereditary aspects of the disease, which helped in diagnosis and understanding of its mechanism of manifestation.
Epidemiology
The prevalence of fructose-1,6-bisphosphatase deficiency is quite low, occurring in approximately 1 in 2 million live births. However, the condition can occur in all ethnic groups. The use of modern molecular diagnostic techniques has significantly improved the diagnosis of the disease, which in turn has identified more cases in previously undiagnosed individuals. With the development of genetic research and increased awareness in the medical community, the number of reported cases is expected to increase.
Genetic predisposition to this disease
Fructose-1,6-bisphosphatase deficiency is caused by mutations in the PFKFB2 gene, located on chromosome 5. This gene codes for an enzyme involved in catalyzing the reaction responsible for converting fructose-1,6-bisphosphate into glucose during gluconeogenesis. There are currently more than 50 different mutations associated with the disease. Most are recessive, indicating that mutations must be inherited from both parents for the disease to manifest in offspring.
Risk factors for the development of this disease
Risk factors for fructose-1,6-bisphosphatase deficiency include:
- Hereditary predisposition: the disease is recessive and is transmitted from parents
- Race: The disease is more common in some ethnic groups
- Age: Symptoms are most often seen in young children
Physical risk factors may include major stressors to the body, such as infections, injuries, and surgeries. Chemical factors are less obvious, but the effects of toxic compounds on metabolism can potentially worsen the condition of patients.
Diagnosis of this disease
The main symptoms of fructose-1,6-bisphosphatase deficiency include:
- Hypoglycemia: low blood glucose levels
- Lactatosis: high levels of lactic acid in the blood
- Exercise intolerance: rapid fatigue and weakness
Laboratory tests often include blood tests for glucose and lactate levels, as well as molecular genetic tests to confirm the diagnosis. Radiological examinations, such as liver ultrasound, may reveal fatty degeneration of the organ. Differential diagnosis should include other metabolic disorders, such as glycogenoses and other enzyme deficiencies.
Treatment
General treatment for fructose-1,6-bisphosphatase deficiency is based on blood sugar control. The main treatment method includes:
- Dietary correction: regular meals rich in carbohydrates
- Avoidance of hypoglycemic states: use glucagon if necessary
Pharmacological treatment is usually aimed at normalizing metabolism. In rare cases, surgery may be required to correct associated disorders. Other treatments include support in the form of diet and individually tailored physical activity plans.
List of medications used to treat this disease
Treatment for fructose-1,6-bisphosphatase deficiency may include:
- Glucose: To quickly raise blood sugar levels
- Glucagon: for emergency relief in cases of acute low glucose
There are currently no specific means aimed at correcting metabolic disorders. All emphasis is placed on maintaining normal sugar levels and preventing crises.
Disease monitoring
Monitoring the patient's condition requires regular examinations:
- Conducting a blood test for glucose and lactate levels
- Liver condition assessment using ultrasound
- Psychological support, especially for children
The prognosis of the disease depends on timely diagnosis and adequate treatment. Complications may include permanent metabolic disorders, developmental problems and concomitant diseases.
Age-related features of the disease
Studies show that in newborns and young children the disease may be more acute, manifesting itself more often in various metabolic crises. At an older age, patients can adapt to the condition, but it is important to consider that physical activity, without proper preparation, can lead to exacerbations. Adult patients may also face new lifestyle challenges associated with changes in diet and stress.
Questions and Answers
- What is the main symptom of fructose-1,6-bisphosphatase deficiency? — The main symptom is hypoglycemia, which can manifest itself as weakness, loss of consciousness and convulsions.
- How is this disease diagnosed? — Diagnostics includes a clinical examination, blood tests for glucose and lactate levels, as well as molecular genetic tests.
- What treatment methods are available? — Treatment mainly includes nutritional correction, drug support and, in some cases, surgical intervention.
- What is the prognosis for patients with this disease? — The prognosis depends on timely diagnosis and treatment; many patients can lead a virtually normal life with proper monitoring.
- What are the risk factors for this disease? — The main risk factor is hereditary predisposition, as well as racial predisposition observed in part of the population.
Dr. Oleg Korzhikov advises:
“Timely detection and diagnosis are the key to successful treatment. It is especially important for patients with fructose-1,6-bisphosphatase deficiency to monitor their condition. They should avoid long pauses between meals and be careful about physical activity. Regular communication with a doctor and psychological support will help cope with the disease.”
